ArticleCell death & disease2026

Targeted inhibition of the CREB1-CtIP axis enhances the efficacy of abiraterone combined with radiotherapy in prostate cancer.

Xu Han et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.